Inhibition of Human Pancreatic Cancer Cell Proliferation by Devil's Club Oplopanax horridus and Its Polyacetylene Bioactive Compound

REFERENCES

• American Cancer Society: Cancer facts and figures, 2013 Retrieved from http://www.cancer.org/research/cancerfactsfigures/cancerfactsfigures/cancer-facts-figures-2013
   Google Scholar
• Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, et al.: (eds) SEER Cancer Statistics Review, 1975–2011 Bethesda, MD: National Cancer Institute. Retrieved from http://seer.cancer.gov/csr/1975_2011/
   Google Scholar
• Kallifatidis G, Labsch S, Rausch V, Mattern J, Gladkich J, et al.: Sulforaphane increases drug-mediated cytotoxicity toward cancer stemlike cells of pancreas and prostate. Mol Ther 19, 188–195, 2011.
   PubMed Web of Science ®Google Scholar
• Zhou W, Kallifatidis G, Baumann B, Rausch V, Mattern J, et al.: Dietary polyphenol quercetin targets pancreatic cancer stem cells. Int J Oncol 37, 551–561, 2010.
   PubMed Web of Science ®Google Scholar
• Cui J, Sun R, Yu Y, Guo S, Zhao G, et al.: Antiproliferative effect of resveratrol in pancreatic cancer cells. Phytother Res 24, 1637–1644, 2010.
   PubMed Web of Science ®Google Scholar
• Yu Y, Hamza A, Zhang T, Gu M, Zou P, et al.: Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 79, 542–551, 2010.
   PubMed Web of Science ®Google Scholar
• Nair V, Dai Z, Khan M, and Ciolino HP: Pomegranate extract induce cell cycle arrest and alters cellular phenotype of human pancreatic cancer cells. Anticancer Research 31, 2699–2704, 2011.
   PubMed Web of Science ®Google Scholar
• Tai J, Cheung S, Cheah S, Chan E, and Hasman D: In vitro anti-proliferative and antioxidant studies on Devil's Club Oplopanax horridus. J Ethnopharmacol 108, 228–235, 2006.
   PubMed Web of Science ®Google Scholar
• Tai J, Cheung S, Chan E, and Hasman D: Inhibition of human ovarian cell lines by Devil's club Oplopanax horridus. J Ethnopharmacology 127, 478–485, 2010.
   PubMed Web of Science ®Google Scholar
• Li XL, Sun S, Du GJ, Qi LW, Williams S, et al.: Effects of Oplopanax horridus on human colorectal cancer cells. Anticancer Res 30, 295–302, 2010.
   PubMed Web of Science ®Google Scholar
• Sun S, Li XL, Wang CZ, Williams S, and Yuan CS: Improving anticancer activities of Oplopanax horridus root bark extract by removing water-soluble components. Phytother Res 24, 1166–1174, 2010.
   PubMed Web of Science ®Google Scholar
• Sun S, Du GJ, Qi LW, Williams S, Wang CZ, et al.: Hydrophobic constituents and their potential anticancer activities from Devil's Club (Oplopanax horridus Miq.). J Ethnopharmacol 132, 280–285, 2010.
   PubMed Web of Science ®Google Scholar
• Wang CZ, Zhang Z, Huang WH, Du GJ, Wen XD, et al.: Identification of potential anticancer compounds from Oplopanax horridus. Phytomedicine 20, 999–1006, 2013.
   PubMed Web of Science ®Google Scholar
• McGill CM, Alba-Rodriguez EJ, Li S, Benson CJ, Ondrasik RM, et al.: Extracts of Devil's club (Oplopanax horridus) exerts therapeutic efficacy in experimental models of acute myeloid leukemia. Phytother Res 28, 1308–1314, 2014. doi: 10:1002/ptr.5129 2014.
   PubMed Web of Science ®Google Scholar
• Tai J, Cheung SSC, Ou D, Warnock GL, and Hasman D: Antiporliferation activity of Devil's club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids. Phytomedicine 21, 506–514, 2014.
   PubMed Web of Science ®Google Scholar
• Kobaisy M, Abramowski Z, Lerner L, Saxena G, Hancock RE, et al.: Antimycobacterial polyyenes of Devil's club (Opplopanax horridus), a North American native medicinal plant. Journal of Natural Products 60, 1210–1213, 1997.
   PubMed Web of Science ®Google Scholar
• Minto RE, and Blacklock BJ: Biosynthesis and function of polyacetylenes and allied natural products. Progress in Lipid Research 47, 233–306, 2008.
   PubMed Web of Science ®Google Scholar
• Hasman D, Smith R, Tai J, and Cheung S: Mass spectral study of anti-cancer polyacetylenes in Devil's club (Oplopanax horridus) an important medicinal plant of the Pacific Northwest. 60th ASMS Conference on Mass Spectrometry and Allied Topics Proceedings TP314, 2012.
   Google Scholar
• Soldevila G, Buscema M, Marini V, Sutton R, James RF, et al.: Transfection with SV40 gene of human pancreatic endocrine cells. J Autoimmun 4, 381–396, 1991.
   PubMed Web of Science ®Google Scholar
• Vives-Pi M, Somoza N, Fernández-Alvarez J, Vargas F, Caro P, et al.: Evidence of expression of endotoxin receptors CD14, toll-like receptors TLR4 and TLR2 and associated molecule MD-2 and of sensitivity to endotoxin (LPS) in islet beta cells. Clin Exp Immunol 133, 208–218, 2003.
   PubMed Web of Science ®Google Scholar
• Chou TC: Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70, 440–446, 2010.
   PubMed Web of Science ®Google Scholar
• Johnson VL, Ko SCW, Holmstrom TH, Eriksson JE, and Chow SC: Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis. J. of Cell Science 111, 2941–2953, 2000.
   Google Scholar
• Huang WH, Zhang QW, Meng LZ, Yuan CS, Wang CZ, et al.: Oplopanphesides A-C, three new phenolic glycosides from the root barks of Oplopanax horridus. Chem Pharm Bull (Tokyo) 59, 676–679, 2011.
   PubMed Web of Science ®Google Scholar
• Calway T, Du GJ, Wang CZ, Huang WH, Zhao J, et al.: Chemical and pharmacological studies of Oplopanax horridus, a North American botanical. J Nat Med 66, 249–256, 2012.
   PubMed Web of Science ®Google Scholar
• Butz J, Wickstrom E, and Edwards E: Characterization of mutations and loss of heterogyzosity of p53 and K-ras2 in pancreatic cancer cell lines by immobilized polymerase chain reaction. BMC Biotechnology 3, 11–16, 2003.
   PubMed Web of Science ®Google Scholar
• Serçin O, and Kemp MG: Characterization of functional domains in human Claspin. Cell Cycle 10, 1599–1606, 2011.
   PubMed Web of Science ®Google Scholar
• Kostin SF, McDonald DE, and McFadden DW: Inhibitory effects of (−)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro. J Surg Res 177, 255–262, 2012.
   PubMed Web of Science ®Google Scholar
• Wei J, Liu M, Liu H, Wang H, Wang F, et al.: Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreatic cancer cells. J Appl Toxicol 33, 756–765, 2013.
   PubMed Web of Science ®Google Scholar
• Ling Q, Xu X, Wei X, Wang B, Zhou B, et al.: Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res 30, 66–71, 2011.
   PubMed Web of Science ®Google Scholar
• Trauzold A, Schmiedel S, Roder C, Tams C, Christgen M, et al.: Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells. British J of Cancer 89, 1714–1721, 2003.
   PubMed Web of Science ®Google Scholar
• Basu A, and Haldar S: The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death. Molecular Human Reproduction 4, 1099–1109, 1998.
   PubMed Web of Science ®Google Scholar
• Beckerman R, and Prives C: Transcriptional Regulation by p53. Cold Spring Harb Perspect Biol 2, a000935, 2010.
   PubMed Web of Science ®Google Scholar
• Doudican N, Wen SY, Mazumder A, and Orlow SJ: Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways. Oncology Reports 28, 1851–1858, 2012.
   PubMed Web of Science ®Google Scholar
• Tai J, Cheung SS, and Hasman D: Human ovarian cancer multicellular spheroids: a model for testing antiproliferation activity of Devil's club (Oplopanax horridus) and anticancer agents. Planta Med 80, 662–670, 2014.
   PubMed Web of Science ®Google Scholar